<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03407313</url>
  </required_header>
  <id_info>
    <org_study_id>CLP-0002</org_study_id>
    <nct_id>NCT03407313</nct_id>
  </id_info>
  <brief_title>CONFORM: Rotational Fractional Resection for Submental Contouring</brief_title>
  <official_title>The CONFORM Study: A Multi-center Study to Evaluate the Safety and Efficacy of Rotational Fractional Resection on Submental Contouring</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Recros Medica, Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Recros Medica, Inc.</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_unapproved_device>No</is_unapproved_device>
    <is_ppsd>No</is_ppsd>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study will evaluate the safety and efficacy of rotational fractional resection (RFR) to
      improve neck contouring. RFR is used to remove loose skin and fat.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This is a prospective, multi-center, single-arm (non-randomized), interventional cohort,
      non-significant risk (NSR) study designed to investigate the efficacy and safety of
      Rotational Fractional Resection (skin resection and focal lipectomy) in patients with mild to
      moderate submental fat and mild to moderate submental skin laxity. The total duration of
      study participation for each subject is approximately up to 7 months for each subject from
      the screening visit to the exit visit. The follow-up period will be approximately 6 months
      after the procedure. Eligible subjects will complete a total of 8 study visits: screening,
      procedure, and follow-up visits at 1, 7, 14, 30, 90 and 180 days post-procedure.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 8, 2018</start_date>
  <completion_date type="Anticipated">November 2018</completion_date>
  <primary_completion_date type="Anticipated">August 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Improved Submental Contouring</measure>
    <time_frame>Pre-treatment and 90 days after treatment</time_frame>
    <description>Correct identification of post-treatment images by three blinded independent reviewers in more than 50% of subjects</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Improved Skin Laxity</measure>
    <time_frame>Pre-treatment and 90 days after treatment</time_frame>
    <description>One grade or better reduction in score on Submental Skin Laxity (0 = none, 1 = mild, 2 = moderate, 3 = severe, 4 = very severe)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Improved Lipodystrophy</measure>
    <time_frame>Pre-treatment and 90 days after treatment</time_frame>
    <description>One grade or better reduction in score on Submental Lipodystrophy Scale (0 = none, 1 = mild, 2 = moderate, 3 = severe, 4 = very severe)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Subject Satisfaction</measure>
    <time_frame>90 days after treatment</time_frame>
    <description>Subject satisfaction of the procedure as assessed using the Subject Satisfaction Questionnaire</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Skin Laxity</condition>
  <condition>Lipodystrophy</condition>
  <arm_group>
    <arm_group_label>Rotational fractional resection</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Single treatment of skin resection and focal lipectomy (removal of loose skin and fat)</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Rotational fractional resection</intervention_name>
    <description>Single treatment of skin resection and focal lipectomy (removal of loose skin and fat)</description>
    <arm_group_label>Rotational fractional resection</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Healthy male or female, at least 30 years old

          -  Moderate submental (neck) fat

          -  Mild to moderate submental (neck) skin laxity (loose skin)

          -  Willing and able to provide informed consent

          -  Willing and able to comply with all protocol requirements

          -  Willing to limit direct sun exposure and use sunscreen for duration of the study

          -  Agree to maintain weight for duration of the study

          -  Willing to have photographs taken that could identify the participant

        Exclusion Criteria:

          -  Previous intervention to treat submental fat or skin laxity

          -  Use of aspirin, ibuprofen, naproxen, or Vitamin E within 14 days of the procedure

          -  Sensitivity to local anesthesia

          -  Severe acne, cystic acne or acne scars on neck

          -  Trauma of chin or neck area

          -  Skin infection or rash on neck

          -  Psoriasis, eczema, rosacea, or vitiligo

          -  History of scarring

          -  History or current symptoms of dysphagia

          -  Chronic or persistent coughing

          -  Body mass index (BMI) &gt; 30

          -  Clinically significant bleeding disorder

          -  Anemia, kidney disease, or liver disease
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>30 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Edward W Knowlton, MD</last_name>
    <role>Study Director</role>
    <affiliation>Recros Medica, Inc.</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Robin McIntosh</last_name>
    <phone>714-309-7667</phone>
    <email>rmcintosh@recrosmedica.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Aesthetx</name>
      <address>
        <city>Campbell</city>
        <state>California</state>
        <zip>95008</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kyralyn Kawasaki-Yee, RN, BSN</last_name>
      <phone>408-559-7117</phone>
      <email>kyralyn@aesthetx.com</email>
    </contact>
    <investigator>
      <last_name>Kamakshi R Zeidler, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>R Laurence Berkowitz, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Steve Yoelin, MD Medical Associates, Inc.</name>
      <address>
        <city>Newport Beach</city>
        <state>California</state>
        <zip>92663</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jo Lee</last_name>
      <phone>949-548-2711</phone>
      <email>auxiliary2@aol.com</email>
    </contact>
    <contact_backup>
      <last_name>Thao Le</last_name>
      <phone>949-548-2711</phone>
      <email>letn89@gmail.com</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Roseville Facial Plastic Surgery</name>
      <address>
        <city>Roseville</city>
        <state>California</state>
        <zip>95661</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Elizabeth Langlois</last_name>
      <phone>916-773-0395</phone>
      <email>Elizabeth.rfps@gmail.com</email>
    </contact>
    <contact_backup>
      <last_name>Kathy Kettenhofen, CCMA</last_name>
      <phone>916-773-0395</phone>
      <email>kkettenhofen@sacent.com</email>
    </contact_backup>
    <investigator>
      <last_name>Jonathan M Sykes, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>David J Kiener, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>DeNova Research</name>
      <address>
        <city>Chicago</city>
        <state>Illinois</state>
        <zip>60611</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Selika Gutierrez- Borst, MS, RN</last_name>
      <phone>312-335-2070</phone>
      <email>selika@denovaresearch.com</email>
    </contact>
    <investigator>
      <last_name>Steven H Dayan, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Zel Skin &amp; Laser Specialists</name>
      <address>
        <city>Edina</city>
        <state>Minnesota</state>
        <zip>55424</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mona Selim</last_name>
      <phone>952-929-8888</phone>
      <email>mona.selim@unitedskin.com</email>
    </contact>
    <investigator>
      <last_name>Brian Zelickson, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Karl Vance, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>May 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 16, 2018</study_first_submitted>
  <study_first_submitted_qc>January 16, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">January 23, 2018</study_first_posted>
  <last_update_submitted>May 16, 2018</last_update_submitted>
  <last_update_submitted_qc>May 16, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">May 18, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Submental fullness</keyword>
  <keyword>Submental fat</keyword>
  <keyword>Loose skin</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Lipodystrophy</mesh_term>
    <mesh_term>Cutis Laxa</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

